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Abstract: Nanotechnology is addressing major urgent needs for cancer treatment. We conducted
a study to compare the frequency of 3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1,2-α]
purin-10(3H)-one deoxyguanosine (M1dG) and 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG)
adducts, biomarkers of oxidative stress and/or lipid peroxidation, on human hepatocarcinoma
HepG2 cells exposed to increasing levels of Fe3O4-nanoparticles (NPs) versus untreated cells at
different lengths of incubations, and in the presence of increasing exposures to an alternating magnetic
field (AMF) of 186 kHz using 32P-postlabeling. The levels of oxidative damage tended to increase
significantly after ≥24 h of incubations compared to controls. The oxidative DNA damage tended
to reach a steady-state after treatment with 60 µg/mL of Fe3O4-NPs. Significant dose–response
relationships were observed. A greater adduct production was observed after magnetic hyperthermia,
with the highest amounts of oxidative lesions after 40 min exposure to AMF. The effects of magnetic
hyperthermia were significantly increased with exposure and incubation times. Most important,
the levels of oxidative lesions in AMF exposed NP treated cells were up to 20-fold greater relative to
those observed in nonexposed NP treated cells. Generation of oxidative lesions may be a mechanism
by which magnetic hyperthermia induces cancer cell death.
Keywords: magnetic therapy; nanotoxicity; M1dG; 8-oxodG; human hepatocarcinoma cells
1. Introduction
The use of nanotechnology in medicine is of interest for cancer diagnosis and treatment. In regards
to treatment, a number of substances are currently under investigation for drug delivery, varying
from liposomes to various polymers and magnetic metals [1–4]. In some cases, the characteristic
properties of nanoparticles (NPs) result in their multifunctional potential for simultaneous early
detection and treatment of malignant cell growth, such as those of Fe3O4-NPs [5–7]. For example,
magnetic hyperthermia is a technique that utilizes the administration of Fe3O4-NPs into tumor sites
and the exposure to alternating magnetic field (AMF) to kill cancer cells by heating. NP properties
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have been associated with a number of toxic effects, such as chromosomal aberrations, DNA strand
breakage, oxidative damage to DNA and mutations [8,9]. Use of NPs along with AMF has been
reported to enhance genotoxicity via oxidative stress [10]. In the current study, we focus on the type of
genotoxicity in more detail.
A number of assays have been used for the detection of NP-related oxidative damaged to
DNA, especially of 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG), in various experimental cell
lines [11]. The interest in 8-oxodG is due to the fact that it is a widely abundant oxidative lesion.
Nevertheless, other kinds of oxidative lesions have also been identified in DNA, including the exocyclic
3-(2-deoxy-β-D-erythropentafuranosyl)pyrimido[1,2-α]purin-10(3H)-one–deoxyguanosine (M1dG)
adducts [12], that may be applied to nanotoxicology testing. In particular, the exposure to Fe3O4-NPs
has been associated with enhanced oxidative stress [13]. This overproduction of reactive oxygen species
(ROS) may induce lipid peroxidation (LPO) as well as M1dG and 8-oxodG [12]. LPO is a process of
oxidation of polyunsaturated fatty acids due to the presence of several double bonds in their structure
and it involves production of peroxides, ROS, and other reactive species, such as malondialdehyde
(MDA). MDA is a reactive LPO by-product, which interacts with DNA forming M1dG adducts [14].
Both M1dG and 8-oxodG, if not repaired, may induce mutations, such as base pair and frameshift
mutations [15] or G:C to T:A transversions [16]. Furthermore, one of the more critical sites on DNA
that can be damaged by oxidative damage is the tumor suppressor P53 [17], a gene involved in cell cycle
arrest, DNA repair, senescence, and apoptosis [18]. Early investigations have also indicated that great
amounts of both M1dG and/or 8-oxodG adducts are associated to cancer development and tumor
progression [17,19–22], therefore these biomarkers are considered worthy indicators for carcinogenesis
or mutagenesis events.
Herein, we report a toxicology study aimed at comparing the production of both exocyclic M1dG
and 8-oxodG adducts, biomarkers of oxidative stress and/or LPO [23], in human hepatocarcinoma
HepG2 cells exposed to Fe3O4-NPs of 50 nm-size in presence or absence of increasing exposures to
AMF and prolonged incubations compared to control cells. The levels of exocyclic M1dG and 8-oxodG
adducts were examined by 32P-postlabeling [24–26]. Our aim was to investigate the mechanisms
underlying the genotoxic effects caused by magnetic hyperthermia. Considering the technical
development and the current and future use of this therapy in cancer treatment [27], an improved
understanding of the mechanisms of action of magnetic hyperthermia is important.
2. Results
2.1. Fe3O4-Nanoparticles and Exocyclic M1dG Adducts
One of the purpose of the present study was to evaluate the generation of exocyclic M1dG adducts
induced by the treatment with increasing amounts of Fe3O4-NPs, ranging from 30 to 60–90 µg/mL,
at different incubation times, from 1 to 48 h. As shown in Table 1, no effects were observed at each
concentration for dosages at 2 h of incubations. However, the production of exocyclic M1dG adducts
per 106 normal nucleotides was increased, up to about two-fold, in HepG2 cells which were treated with
NP dosages for incubation times of ≥24 h compared to untreated samples. In our model, the difference
between M1dG adducts of cells exposed to increasing amounts of Fe3O4-NPs and basal adduct levels
of control cells, i.e., 0.4 ± 0.1 (SE), was generally significant, all p < 0.05, after ≥24 h of incubation
times, with exception of sample exposed to 30 µg/mL of NPs for 24 h (p = 0.057). Table 1 shows that
the highest levels of M1dG, i.e., 0.9 ± 0.1 (SE), were found in HepG2 cells treated with 60 µg/mL of
Fe3O4-NPs. At higher dosages (90 µg/mL), the treatment was not associated with further adduct
production, possibly due to the onset of excessive citoxicity. A significant dose–response relationship
was found, with a p-value for the trend <0.001. The levels of NP-related M1dG adducts were then
compared with those caused by the xanthine/xanthine oxidase system, a ROS-generating system [28].
The frequency of exocyclic M1dG adducts in HepG2 cells treated with Fe3O4-NPs was about three-fold
lower compared to that induced by the ROS-generating system (Table 1).
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Table 1. Mean levels of 3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1,2-α]purin-10(3H)-one
deoxyguanosine (M1dG) adducts and 8-hydroxy-2′-deoxyguanosine (8-oxodG) per 106 normal
nucleotides in HepG2 cells after treatment with 30, 60 or 90 µg/mL of Fe3O4-nanoparticles and
prolonged incubation times compared to control cells. Adduct levels caused by a free radical-generating
system in our model are reported, as positive internal control.
Exocyclic M1dG and 8-oxodG Lesions
N M1dG± SE p-Value 8-oxodG± SE p-Value
Adduct background
Control cells
Incubation times
24 h a 10 0.4 ± 0.1 3.2 ± 0.2
48 h a 10 0.4 ± 0.1 3.1 ± 0.2
Adduct levels of magnetic nanoparticle treated cells
Treated cells
30 µg/mL
Incubation times
24 h 10 0.5 ± 0.1 0.057 b 11.2 ± 0.8 <0.05 b
48 h 10 0.6 ± 0.1 <0.05 b 14.7 ± 0.4 <0.05 b
60 µg/mL
Incubation times
24 h 10 0.8 ± 0.1 <0.05 b 18.4 ± 2.8 <0.05 b
48 h 10 0.9 ± 0.1 <0.05 b 19.4 ± 1.4 <0.05 b
90 µg/mL
Incubation times
24 h 10 0.7 ± 0.1 <0.05 b 17.1 ± 1.7 <0.05 b
48 h 10 0.8 ± 0.1 <0.05 b 18.0 ± 1.8 <0.05 b
Adduct levels of positive internal control
Free radical-generating system
0.2 mM xanthine/1.0 mU xanthine oxidase
Incubation times
24 h 10 1.9 ± 0.1 <0.05 b 4.6 ± 0.2 <0.05 b
48 h 10 2.2 ± 0.1 <0.05 b 5.4 ± 0.2 <0.05 b
0.2 mM xanthine/5.0 mU xanthine oxidase
Incubation times
24 h 10 2.9 ± 0.6 <0.05 b 8.3 ± 0.2 <0.05 b
48 h 10 2.7 ± 0.4 <0.05 b 9.3 ± 0.4 <0.05 b
a Reference levels; b p-values vs. appropriated controls.
2.2. Fe3O4-Nanoparticles and 8-oxodG Adducts
We next investigated the generation of 8-oxodG in our experimental model. Table 1 reports
that there were no effects at each NP concentrations with ≤120 min incubations, whereas adduct
production was significantly increased, up to six-fold, after ≥24 of incubations compared to untreated
cells. The highest levels of 8-oxodG per 106 normal nucleotides, were found after treatment with
60–90 µg/mL of Fe3O4-NPs for period of incubation of ≥24, 18.4 ± 2.8 (SE), and 19.4 ± 1.4 (SE),
respectively. The difference of 8-oxodG among HepG2 cells treated with various concentrations of
Fe3O4-NPs relative to basal adduct levels, i.e., 3.2 ± 0.2 (SE), was always significant, all p < 0.05, after
≥24 h of incubations. The mean amounts of 8-oxodG detected in control cells (3.1–3.2 8-oxodG per 106
normal nucleotides) was in the range of 1.0 and 5.0 per 106 normal dG, which is typically observed in
cultured cells [29]. As shown in Table 1, the association between 8-oxodG and NP levels was linear
at low dosages, but tended to reach a steady-state at higher exposures. A significant dose–response
relationship was observed, p-value for the trend <0.001. The amounts of NP-related 8-oxodG were
then compared with those detected after treatment with the xanthine/xanthine oxidase system. Table 1
reports that the generation of 8-oxodG was about two-fold higher in HepG2 cells treated with the
Fe3O4-NPs compared to those exposed to the ROS-generating system.
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2.3. Magnetic Nanoparticles, Alternating Magnetic Field and Exocyclic M1dG Adducts
We also evaluated the genotoxicity of Fe3O4-NPs (90 µg/mL) after increasing exposures,
i.e., 20–40 min, to an AMF applied at 186 kHz frequency. Table 2 shows that a significant production of
exocyclic M1dG adducts, up to a 30-fold increment, was detected in treated cells after AMF exposures
compared to controls. The genotoxic effect increased with both exposure and incubation times, with
p-value for the trend <0.001. The highest value of the exocyclic M1dG adducts of 15.9 ± 6.7 (SE) was
detected in HepG2 cells containing 90 µg/mL of Fe3O4-NPs after 20 min of AMF exposure and 48 h
of incubation. The difference of M1dG was significant, all p < 0.05. Table 2 indicates that the levels
of exocyclic M1dG adducts were also higher, up to 20-fold, in NP treated cells after AMF exposures
relative to nonexposed NP treated cells, all p < 0.05.
Table 2. Mean levels of 3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1,2-α]purin-10(3H)-one
deoxyguanosine (M1dG) adducts and 8-hydroxy-2′-deoxyguanosine (8-oxodG) adducts per 106 normal
nucleotides in 90 µg/mL Fe3O4-nanoparticle (NP) treated HepG2 cells in presence or absence of
alternating magnetic field (AMF) exposures and prolonged incubation times compared to control cells.
Exocyclic M1dG and 8-oxodG Adducts
N M1dG± SE p-Value 8-oxodG± SE p-Value
Adduct background in presence or absence of AMF exposures
Control cells
Nonexposed to AMF
Incubation times
24 h a 10 0.4 ± 0.1 3.2 ± 0.2
48 a 10 0.4 ± 0.1 3.1 ± 0.2
Exposed to AMF (20 min)
Incubation times
24 h a 10 0.5 ± 0.1 3.2 ± 0.2
48 a 10 0.5 ± 0.1 3.3 ± 0.3
Exposed to AMF (40 min)
Incubation times
24 h a 10 0.5 ± 0.1 3.4 ± 0.2
48 a 10 0.5 ± 0.1 3.9 ± 0.3
Adduct levels of treated cells in presence or absence of AMF exposures
NP treated cells
Nonexposed to AMF
Incubation times
24 h a 10 0.7 ± 0.1 <0.05 b 16.7 ± 1.7 <0.05 b
48 a 10 0.8 ± 0.1 <0.05 b 21.2 ± 1.9 <0.05 b
Exposed to AMF (20 min)
Incubation times
24 h a 10 4.6 ± 0.5 <0.05 b 40.3 ± 3.3 <0.05 b
48 a 10 6.9 ± 0.6 <0.05 b 69.3 ± 1.4 <0.05 b
Exposed to AMF (40 min)
Incubation times
24 h a 10 6.4 ± 1.4 <0.05 b 36.5 ± 4.0 <0.05 b
48 a 10 15.9 ± 6.7 <0.05 b 79.3 ± 1.1 <0.05 b
a Reference levels; b p-values vs. appropriated referent cells.
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2.4. Magnetic Nanoparticles, Alternating Magnetic Field and 8-oxodG Adducts
We investigated the association between the production of 8-oxodG in 90 µg/mL Fe3O4-NP
treated cells after exposure (20 or 40 min) to an AMF applied at 186 kHz. As reported in Table 2,
the generation of 8-oxodG was significantly increased, up to 25-fold, in treated cells after AMF exposure
compared to controls. The effect was associated to both exposure and incubation, with p-value for the
trend <0.001. The highest value of 8-oxodG of 79.3 ± 1.1 (SE) was detected in treated cells that were
exposed to AMF for 40 min and incubated for 48 h. Table 2 shows that the levels of 8-oxodG were
also higher, up to a five-fold increase, in treated cells after AMF exposure relative to nonexposed NP
treated cells, all p < 0.05.
Since heating curves cannot be directly recorded during the experimental sessions because of
sample sterility, kinetic pathways of temperature increase were recorded in solutions of Fe3O4-NPs
containing the same amount of particles as the samples described in the manuscript (Figure 1).
Temperature rise of the dispersion during AMF exposure was measured by an optical fiber probe
(CEAM Vr18CR-PC) and it was recorded every second during the experimental measurements.
The samples were inserted in a homemade polyethylene sample holder, surrounded by glass wool for
thermal isolation, and then in the copper coil. The sample mass (m = 0–3 g) was chosen to minimize
the effects of magnetic field inhomogeneity inside the sample.
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Figure 1. Kinetics of temperature increase versus exposure time for block polymer coated Fe3O4-NPs
90 µg/mL (blue curv ) nd 60 µg/mL (red curve).
2.5. Fe3O4-Nanoparticle Internalization
The uptake of Fe3O4-NPs conjugated with fluorescent dye Dylight650 was monitored by
fluorescent microscopy. NP fluorescence inside cells was measured with background subtraction.
As shown in Figure 2A–C, the NPs were internalized at the concentration of 90 µg/mL by HepG2 cells
i suffi ient quantity to be detect d after 240 min (Figure 2C). A significant increase in fluorescence
intensity was indeed observed only at that i cubation time, p < 0.0001 (Figure 2D). The lack of genotoxic
effects in Fe3O4-NPs treated cells at lower incubation time is apparently due to a lack of significant
cellular penetration of NPs during this initial period.
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Figure 2. Human hepatocarcinoma (HepG2) cells incubated with 90 µg/mL Fe3O4-nanoparticles
conj gated with fluorescent dye Dylight650. The images of reated cells at selected incubation times
are shown: 0 min (A); 120 min (B); and 240 min (C). The increments in fluoresce e in ensi y at
each incubation times, mean ± standard error (SE , are reported in the insert (D). Scal bar: 10 µm;
**** p < 0.0001; n.s. = not signific nt.
3. Discussion
The potential therapeutic benefits of Fe3O4-NPs [30] must consider their potential for off-target
toxicity [8,9,31–33]. Fe3O4-NPs, if undirected, are mainly sequestere in liver tissue for elimination.
Hence, we studied human hepatocarcinoma cells for NP-related toxicity. In particular, we investigated
the pro-oxidant properties of Fe3O4-NPs in towards DNA. We aske whether experimental cells
treated with increasing NP co centrations experienced genotoxic effects at various times of incubation.
A further purpose of the present study was to i vestigate the generation of oxidative DNA lesions
in Fe3O4-NP treated cells after AMF exposures. Two different biomarkers, i.e., exocyclic M1dG and
8-oxodG adducts, of oxidative stress and/or LPO [23], were meas red by 32P-postlabeling.
High dosages of Fe3O4-NPs are expected to significantly increase cellular ROS and the production
of oxidative damage to DNA [11]. This was found in our model, where the administration of increased
NP concentrations (30, 60 or 90 µg/mL) was significantly associated with higher levels of both exocyclic
M1dG and 8-oxodG adducts in HepG2 cells after ≥24 h of incubation in comparison to untreated cells.
No genotoxic effects were detected by each concentration dosages at ≤120 min of incubations, possibly
due to a lack of penetration of NPs into cellular membrane of HepG2 cells during this initial period,
as shown by fluorescent microscopy (Figure 2). We found a significant dose–response relationship
between oxidized DNA lesions and Fe3O4-NPs. Nevertheless, while the associations with adduct
production tended to be linear at low exposure, it was sublinear at high dosages, perhaps due to
excessive cytotoxicity. We assume in this study that Fe3O4-NPs act as a pro-oxidant by causing
iron-dependent Fenton reactions that generate first .OH and, then, .C radicals, through LPO induction,
which are important intermediates that lead to the formation of oxidative DNA lesions. Consequently,
the addition of Fe3O4-NPs to HepG2 cells increases the oxidation of genomic DNA, measured as
promutagenic lesions. The toxic action of magnetic therapy may be mediated by several mechanisms,
as shown in Figure 3.
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Our findings are in keeping with a series of earlier reports which have shown adverse effects
associated with the exposure to Fe3O4-NPs in mammalian liver cells [11]. For example, Lin and
coworkers [34] analyzed the toxicity of Fe3O4-NPs on human hepatocytes after 24 h of incubation
using various assays including the comet assay and other biomarkers of oxidative stress, such as
glutathione peroxidase, superoxide dismutase and MDA. In that study, the treatment with NPs
was associated with both nuclear condensation and chromosomal DNA fragmentation. Significant
reductions of cellular levels of glutathione peroxidase and superoxide dismutase levels as well as
increased MDA were also observed. Sadeghi and coworkers [35] analyzed the effects of Fe3O4-NP
exposures (75–100 µg/mL) in HepG2 cells after 12–24 h of treatment. Higher oxidative damage
to DNA that was both concentration and time dependent was detected. In another study, Ma and
coworkers [36] analyzed the effects of increasing dosages up to 40 mg/kg of Fe3O4-NPs on mice after
seven days of treatment. Significant increments of both 8-oxodG and DNA-protein crosslinks were
observed in liver tissue.
Magnetic hyperthermia is a technique based on the use of Fe3O4-NPs to remotely induce local
heat in cancer cells when AMF is applied. Increased production of oxidative stress has been associated
with this therapeutic approach [10,37]. We evaluated whether DNA-damaging effects induced by
Fe3O4-NPs (90 µg/mL) are intensified by increasing exposures to AMF. Our most striking result
shows that higher exposures to AMF induce a significant production of both exocyclic M1dG and
8-oxodG adducts compared to controls cells. Thus, one important question is whether the increasing
induction of DNA-modifications is correlated to a rising temperature. This is important, since as
known chemical reactions can be promoted by higher temperatures. The effects, shown in the data
reported in Figure 1, showed that oxidative lesions were induced with a temperature rise of 4 ◦C,
but it is reasonable that the punctual heating of each single particle under AMF reaches even higher
temperature that, to date, is not possible to be quantified. The genotoxic effects were also significantly
Int. J. Mol. Sci. 2017, 18, 939 8 of 15
associated with incubation times (24–48 h). The levels of oxidative DNA lesions in AMF exposed
treated cells were also significantly higher in respect to nonexposed NP treated cells. Specifically,
the levels of exocyclic M1dG adducts in AMF exposed NP treated cells are up to 95% higher when
compared to nonexposed NP treated cells. The amounts of 8-oxodG are up to 73% greater in respect
to nonexposed controls. Nevertheless, the levels of M1dG in AMF exposed NP treated HepG2 cells
(30-fold increment vs. nonexposed control cells) was lower than that detected in A549 and BEAS-2B
lung epithelial cells exposed to 10 µM of benzo(a)pyrene (54-fold increment vs. control cells) [38]. Our
findings are in agreement with Shaw and coworkers [37], who observed enhancement of genotoxic
effects by Fe3O4-NPs in cancer cells after magnetic flux using the Comet assay. In that study, magnetic
field exposure increased the levels of DNA double and single strand breaks in cancer cells.
On the one hand, Fe3O4-NPs may absorb the energy from AMF and convert it into heat primarily
through Brownian and Neel relaxations, when exposed to AMF [10]. The heat in turn could simply
increase reaction rates for existing ROS. On the other hand, magnetic therapy could increase formation
of ROS such as hydroxyl radicals at the surface of Fe3O4-NPs [39]. Increased levels of ferrous ions
might form and react with H2O2 produced by mitochondria, inducing ROS generation through the
Fenton reaction [40,41], which causes various kind of oxidative damage to DNA, such as exocyclic
M1dG and 8-oxodG adducts. Alternatively, ROS induction may be attributed to surface coating-cell
interactions. Toxic effects of Fe3O4-NPs may partially derive from chemical reactions between coating
and cell components during phagocytosis [42]. In support to this hypothesis, we showed an association
between oxidative burst of activated cells and M1dG generation [43,44].
The generation of oxidative DNA lesions, such as those caused from Fe3O4-NPs [45], has
intensified interest in nanotoxicology because they are considered one way to induce of authophagy
and apoptosis cell death of cancer cells [46]. When DNA is severely damaged or unrepaired, cells may
remain quiescent and activate pro-survival mechanisms or undergo cell death. Once induced by DNA
injury, autophagy may delay apoptosis in response to genetic damage by sustaining the mechanisms
necessary for DNA repair, or may contribute to cell death when DNA is unrepaired and apoptosis
is defective.
4. Material and Methods
4.1. Fe3O4-Nanoparticles, Cell Culture and Cell Treatments in Presence or Absence of Alternating Magnetic Field
The 50-nm hydrodynamic diameter size (by DLS measurements) block polymer coated Fe3O4-NPs
of 3 mg/mL concentration were obtained from Colorobbia Consulting-Cericol, Italy. HepG2 cells
were routinely cultivated under standard conditions. Cells were incubated in a humidified controlled
atmosphere with a 95% to 5% ratio of air/CO2, at 37 ◦C, with medium that was changed every 3 days.
Trypsinized cells at 30–40% confluence were exposed to increasing levels of Fe3O4-NPs that were
dispersed in cell culture medium to obtain the final concentrations of 30, 60 or 90 µg/mL. Increasing
lengths of incubations were used, i.e., from 60–120 min to 24–48 h. The entire and general image of
strategy of the present research is shown in Figures 4 and 5.
Specifically, the NP concentrations were comparable to those utilized in the studies of Kham and
coworkers [47], and Alarifi and coworkers [48], who found increased toxic effects caused from the
treatments with Fe3O4-NPs of comparable diameter size. Subsequently, the hepatocarcinoma cells,
which were treated with 90 µg/mL of NPs, were exposed to 25 kA/m AMF at a frequency of 186 kHz
with a copper coil of 3 turns and Ø = 100 mm (Celes MP 6/400) for 20 or 40 min exposure times,
and then returned to the incubator for 24 or 48 h of incubation. Cells not exposed to NPs served as
negative control in each experiment. As positive internal control, experimental cells were treated with
0.2 mM xanthine plus 1.0 or 5.0 mU xanthine oxidase, a system capable of generating singlet oxygen
and hydrogen peroxide [28], and incubated for 24–48 h.
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4.2. Preparation of M1dG Reference Adduct Standard
A reference adduct standard w r pared: calf-thymus-DNA was treated with 10 mM MDA
(ICN Biomedicals, Irvine, C , USA), as previously reported [49]. MDA treated calf-thymus-DNA was
diluted with untreated DNA to obtain decreasing levels of the reference adduct standard to generate a
calibration curve.
4.3. Mass Spectrometry Analysis
The levels of exocyclic DNA adducts in MDA treated calf-thymus-DNA sample were analyzed by
mass spectrometry (Voyager DE STR from Applied Biosystems, Framingham, MA, USA), as reported
elsewhere [50].
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4.4. Reference M1dG Standard by 32P-Postlabeling and Mass Spectrometry
The levels of the exocyclic M1dG adducts were 5.0 ± 0.6 per 106 normal nucleotides in MDA
treated calf-thymus-DNA using 32P-postlabeling [24]. The presence of exocyclic M1dG adducts in this
sample was confirmed by matrix-assisted laser desorption/ionization time-of-flight-mass-spectrometry
(MALDI-TOF-MS). A calibration curve was set up by diluting this sample with untreated
calf-thymus-DNA and measuring the decreasing amount of M1dG, R2 = 0.99.
4.5. DNA Isolation and Hydrolysis
DNA from treated and untreated cells was extracted and purified from lysed cells using a
method that requires digestion with ribonuclease A, ribonuclease T1 and proteinase K treatment and
extraction with saturated phenol, phenol/chloroform/isoamyl alcohol (25:24:1), chloroform/isoamyl
alcohol (24:1) and ethanol precipitation [51]. DNA concentration and purity were determined using a
spectrophotometer. Coded DNA samples were subsequently stored at−80 ◦C until laboratory analyses.
Before adduct determination, DNA (2–5 µg) was hydrolyzed by incubation with micrococcal nuclease
(21.45 mU/µL) and spleen phosphodiesterase (6.0 mU/µL) (Sigma Aldrich, St. Louis, MO, USA
and Worthington, NJ, USA) in 5.0 mM Na succinate, 2.5 mM calcium chloride, pH 6.0 at 37 ◦C for
4.5 h [52,53].
4.6. Exocyclic M1dG Adduct Analysis
The generation of M1dG adducts was analyzed by 32P-postlabeling [24]. Hydrolyzed samples
were incubated with nuclease P1 (0.1 U/µL) in 46.6 mM sodium acetate, pH 5.0, and 0.24 mM ZnCl2
at 37 ◦C for 30 min. After nuclease P1 treatment, 1.8 µL of 0.16 mM Tris base was added to the
sample. The nuclease P1-resistant nucleotides were incubated with 7–25 µCi of carrier-free [γ-32P]ATP
(3000 Ci/mM) and polynucleotide kinase T4 (0.75 U/µL) to generate 32P-labeled DNA adducts in bicine
buffer, 20 mM bicine, 10 mM MgCl2, 10 mM dithiotreithol, 0.5 mM spermidine, pH 9.0, at 37 ◦C for
30 min. The generation of M1dG adducts in Fe3O4-NPs treated hepatocarcinoma cells and control cells
were measured using a modified version of 32P-postlabeling [38]. Labeled samples were applied on
polyethyleneimine cellulose thin-layer chromatography plates (Macherey-Nagel, Postfach, Germany).
The chromatographic analysis of M1dG adducts was performed using a low-urea solvent system
known to be effective for the detection of low molecular weight and highly polar DNA adducts:
0.35 M MgCl2 for the preparatory chromatography; and 2.1 M lithium formate, 3.75 M urea pH 3.75
and 0.24 M sodium phosphate, 2.4 M urea pH 6.4 for the two-dimensional chromatography.
Detection and quantification of modified and normal nucleotides, i.e., diluted samples that were
not treated with nuclease P1, was performed by storage phosphor imaging techniques employing
intensifying screens from Molecular Dynamics (Sunnyvale, CA, USA). The intensifying screens were
scanned using a Typhoon 9210 (Amersham, UK). Software used to process the data was ImageQuant
from Molecular Dynamics. After background subtraction, M1dG adducts were expressed as relative
adduct labeling (RAL) = pixel in adducted nucleotides/pixel in normal nucleotides. M1dG levels were
corrected across experiments based on the recovery of reference M1dG adduct standard.
4.7. 8-oxodG Adduct Analysis
Digest DNA was diluted with ultrapure water to 20 ng/µL. Diluted DNA digest was incubated
with 10 µCi of carrier-free [γ-32P]ATP (3000 Ci/mM) (Amersham, UK) and 2 U of polynucleotide
kinase T4 (10 U/µL) (Roche Diagnostics, Indianapolis, IN, USA) to generate 32P-labeled adducts
in the reaction buffer (10×) at 37 ◦C for 45 min [21,52]. 32P-labeled samples were treated with
1.2 U of nuclease P1 (1.9 U/µL) (Sigma Aldrich, St. Louis, MO, USA) in 62.5 mM sodium acetate,
pH 5.0, and 0.27 mM ZnCl2 at 37 ◦C for 60 min (final volume 10 µL) [25,26,53]. 32P-labeled samples
were applied on polyethyleneimine cellulose thin-layer chromatography plates (Macherey-Nagel,
Postfach, Germany). The chromatographic analysis of 8-oxodG, a biomarker of oxidative stress and
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cancer risk [54], has been performed using a chromatographic system known to be effective for the
detection and quantitative analysis of such oxidative lesions [25,26,55–58]. As previously reported [25],
this procedure specifically detects 8-oxodG, which is the only adduct retained in chromatograms
developed in acidic medium. Specifically, an aliquot (2.5 µL) of the labeled solution was applied to the
origin of a chromatogram and developed overnight onto a 3 cm-long Whatman 1 paper wick with
1.5 M formic acid for the one-dimensional chromatography. For the two-dimensional chromatography,
chromatographic plates were developed at the right angle to the previous development with 0.6 M
ammonium formate, pH 6.0. Detection and quantification of 8-oxodG was obtained as described above.
After background subtraction, the levels of 8-oxodG were expressed such as RAL = screen pixel in
8-oxodG spot/screen pixel in total normal nucleotides [25,26]. The levels of the normal nucleotides
were measured as described above. The values measured for the 8-oxodG spot were corrected across
experiments based on the recovery of the internal standard, e.g., 8-oxodG (Sigma Aldrich, St. Louis,
MO, USA).
4.8. Fe3O4-Nanoparticle Internalization
To evaluate the dynamics of cellular internalization, Fe3O4-NPs were conjugated with the
fluorescent dye DyLight650 and imaged by live-cell microscopy. Briefly, HepG2 cells exposed to
90 µg/mL of Fe3O-NPs were cultured in FluoroBrite DMEM media supplemented with 10% FCS,
and kept at 37 ◦C with 5% CO2 during image acquisition. Images were acquired through a 63x HCX
PLANAPO 1.2NA water-immersion objective, using a Leica AM6000 inverted microscope equipped
with a DFC350FX camera. Images were collected before addition of NPs (t = 0) to analyze background
and autofluorescence of experimental cells, and incubated at different incubation times, i.e., 30, 60, 120,
or 240 min. Both transmitted and fluorescence images were collected. Quantification of intracellular
fluorescence was performed using Fiji software [59] by manually drawing regions-of-interest (ROI)
around cells in the brightfield channel and measuring the mean intensity fluorescence in each
region. Mean background fluorescence was measured in each microscopic field (by drawing ROI
not-containing cells) and subtracted from cellular fluorescence values. Fluorescence intensity values
were normalized by the average fluorescence intensity at t = 0.
4.9. Statistical Analysis
The levels of oxidative DNA lesions were expressed as adducted nucleotides per 106 normal
nucleotides. Adduct data were log transformed to stabilize the variance and normalize the
distribution. Baseline characteristics between two groups were compared using independent t-test or
Mann–Whitney U test for continues variables and chi square test for categorical variables. All statistical
tests were two-sided and p < 0.05 was considered to be statistically significant. The data were analyzed
using SPSS 13.0 (IBM SPSS Statistics, New York, NY, USA).
5. Conclusions
The greater production of Fe3O4-NPs-related oxidative DNA lesions after exposures to AMF may
be one of the mechanisms by which magnetic therapy kills cancer cells. Concerning cancer cell death
specifically, the hypothesis that increased levels of oxidative damage to DNA during magnetic therapy
might contribute to kill cancer cells upon greater induction of apoptosis and autophagy seems to be
fair enough. The generation of oxidative DNA lesions might be a further parameter that has to be
maximized to optimize the action of this therapeutic approach.
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